Profil
Ehud Shoshani served as the Chief Executive Officer at Quintiles UK Ltd.
and as the Medical Director at OMRIX Biopharmaceuticals, Inc. and Gamida Cell Ltd.
He also worked as the Vice President-Clinical Affairs at Aevi Genomic Medicine, Inc. Shoshani holds a doctorate degree from Technion-Israel Institute of Technology, which he received in 1978.
Anciens postes connus de Ehud Shoshani
| Sociétés | Poste | Fin |
|---|---|---|
| GAMIDA CELL LTD. | Directeur Technique/Scientifique/R&D | - |
| Quintiles UK Ltd. | President | - |
OMRIX Biopharmaceuticals, Inc.
 OMRIX Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OMRIX Biopharmaceuticals, Inc. specializes in the manufacture and development of biosurgical and passive immunotherapy products. Its product range encompasses hemostatic, surgical, and immunotherapy solutions. The firm offers solutions for bleeding control, surgical operations, and biodefense applications. The company was founded by Robert Taub in 1995 and is headquartered in Somerville, NJ. | Directeur Technique/Scientifique/R&D | - |
| AEVI GENOMIC MEDICINE, INC. | Directeur Technique/Scientifique/R&D | - |
Formation de Ehud Shoshani
| Technion-Israel Institute of Technology | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| GAMIDA CELL LTD. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Aevi Genomic Medicine, Inc.
 Aevi Genomic Medicine, Inc. Pharmaceuticals: MajorHealth Technology Aevi Genomic Medicine, Inc. is a clinical stage biopharmaceutical company, which engaged in the discovery of treatments for rare and orphan diseases. Its research and development efforts leverage an internal genomics platform and an ongoing collaboration with the Center for Applied Genomics (CAG) at The Children's Hospital of Philadelphia (CHOP). The company was founded by Andrew Leonard Pearlman on January 27, 2000 and is headquartered in Wayne, PA. | Health Technology |
| Quintiles UK Ltd. | |
OMRIX Biopharmaceuticals, Inc.
OMRIX Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OMRIX Biopharmaceuticals, Inc. specializes in the manufacture and development of biosurgical and passive immunotherapy products. Its product range encompasses hemostatic, surgical, and immunotherapy solutions. The firm offers solutions for bleeding control, surgical operations, and biodefense applications. The company was founded by Robert Taub in 1995 and is headquartered in Somerville, NJ. | Health Technology |
